• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH INC. BINAX NOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH INC. BINAX NOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19 Back to Search Results
Catalog Number 195-000
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/04/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation is still in progress.A supplemental report will be submitted after completion.Please see related mfr report # (b)(4).
 
Event Description
A customer sent a cumulative report of two false negative results with the id now covid-19 assay.This report represents patient two of two.The customer reported a false negative result from a kitted nasal swab of both nostrils with the binax now covid-19 ag card assay performed on (b)(6) 2020.The customer indicated that confirmation testing with pcr was conducted ((b)(6) 2020) and generated positive results.The customer reported that the patient was asymptomatic.The customer also reported that the patient was not on any treatment and self-quarantining.The customer confirmed there was no death or serious injury and treatment was not impacted/delayed.Per binax now covid-19 ag card product insert intended use: negative results from patients with symptom onset beyond seven days should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed.Negative results do not rule out sars-cov-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.Negative results should be considered in the context of a patient's recent exposures, history and the presence of clinical signs and symptoms consistent with covid-19.Per binax now covid-19 ag card product insert precautions and limitations: inadequate or inappropriate sample collection, storage, and transport may yield false test results.False negative results can occur if the sample swab is not rotated (twirled) prior to closing the card.False results may occur if specimens are tested past 1 hour of collection.Specimens should be tested as quickly as possible after specimen collection.False negative results may occur if inadequate extraction buffer is used (e.G.,<6 drops).False negative results may occur if swabs are stored in their paper sheath after specimen collection.The presence of mupirocin may interfere with the binaxnow covid-19 ag test and may cause false negative results.Due to the risk of false negative results potentially leading to no or delayed treatment, this event shall be reported.
 
Manufacturer Narrative
Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 130445 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing batch records and quality control release testing for kit part number 195-000 / lot 130445 and device part number 195-430h / lot 129163 were reviewed.This lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 130445 showed that the complaint rate is 0.001%.Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue; however, it could possibly be related to the specific patient samples.The available evidence suggests that this device lot is performing within the statements made within package insert related to % test agreement with the expected results by sample concentration.Please see related mfr report # 1221359-2020-00443.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAX NOW COVID-19 AG CARD
Type of Device
LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
alexa wakley
10 southgate road
scarborough, ME 04074
2077305750
MDR Report Key11103166
MDR Text Key239393671
Report Number1221359-2020-00444
Device Sequence Number1
Product Code QKP
UDI-Device Identifier10811877011290
UDI-Public01108118770112901721040910128694130445
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA202537
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/21/2021
Device Catalogue Number195-000
Device Lot Number130445
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/07/2020
Initial Date FDA Received12/31/2020
Supplement Dates Manufacturer Received01/12/2021
Supplement Dates FDA Received02/10/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/29/2020
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age77 YR
Patient Weight73
-
-